Almost 400 cell and gene therapies in US pipeline, finds report
New research has found that there are 362 cell and gene therapies in clinical pipelines in the US, an increase from 2018.
List view / Grid view
New research has found that there are 362 cell and gene therapies in clinical pipelines in the US, an increase from 2018.
New research has found that of the drugs in the pre-registration phase, 10 are expected to become blockbusters over the next six years.
The CMA has cleared the anticipated purchase of gene therapy company Spark Therapeutics by pharmaceutical company Roche Holdings.
Hemlibra has been approved to prevent the frequency of bleeding episodes in patients who have developed FVIII inhibitors...